Depending on how much CBD (and thus THC), you consume, how often you consume it, your body weight and your diet, it’s possible for THC to accumulate in your body in as little as four to six days and trigger a positive drug test. Research has found that THC can be detectable in your system for up to 30 days, but it’s usually only present in heavy cannabis users after the first week.
To hit 50 ng/mL of THC, you’d probably have to consume upwards of 2,000 mg of CBD products that contain 0.3% or less of THC, which is much higher than the average person is likely to take. Even in clinical trials and research studies, people are usually only administered 100-800mg/day.
And in 2018, the CDC released a report that found that more than 50 people in Utah were poisoned by CBD products that actually contained synthetic marijuana commonly known as Spice and K2.
Second, there’s a good chance that the CBD product you’re using contains more than the .3% THC legally allowed. In fact, when Penn Medicine researchers bought CBD products online and then analyzed their ingredients, they found that about one in five contained up to 6.4 mg/ML of THC — high enough to cause impairment.
Why CBD might cause you to fail a drug test
When it comes to marijuana, drug tests typically only screen for THC — the compound in cannabis that gets you “high” — or one of the compounds created when your body metabolizes it. And by law CBD products can only contain up to 0.3% THC.
So you’re in the clear, right? Not quite. There are two ways you could hit that 50 ng/mL mark.
alt=”CBD oil” width=”644″ height=”481″ />Canva
Get the CNET Now newsletter
alt=”urine drug test” width=”1092″ height=”815″ />Canva
Drug tests don’t screen for CBD, but that doesn’t mean you’re in the clear.
CBD, or Cannabidiol, is one of over a hundred cannabinoid compounds found in the Cannabis Sativa, or Hemp, plant.
What Is CBD Oil?
However, there is more to it than that.
Does CBD Oil Show Up On A Drug Test?
But if you’re a professional athlete or your job requires you to take a drug test, you may have heard stories of people failing these screenings and claiming CBD is the culprit.
Background: Sweat testing, an alternative matrix for establishing drug abuse, offers additional benefits to the more common biological samples. The authors developed a procedure using gas chromatography-mass spectrometry to test for Δ9-tetrahydrocannabinol, 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid, cannabinol (CBN), and cannabidiol (CBD) in a sweat patch. The results were compared with urine and hair sample results.
Methods: Urine, hair, and sweat samples were simultaneously collected from 12 patients who were involved, respectively, in forensic case and monitoring abuse. Selectivity, linearity, limit of detection (LOD), limit of quantification (LOQ), recovery, intraday and interday imprecision, and inaccuracy of the quantification procedure were validated. LODs in hair were 0.05 ng/mg for Δ9-tetrahydrocannabinol, CBN, and CBD, and 0.005 ng/mg for 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid. The LOD for sweat was 0.30 ng/patch for all substances. The LOQ in hair was 0.1 ng/mg for Δ9-tetrahydrocannabinol, CBN, and CBD, and 0.01 ng/mg for 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid. The LOQ was 0.4 ng/patch in sweat for each analyte. Cannabinoid in urine was determined by means of immunochemical screening (cutoff 11-nor-Δ-tetrahydrocannabinol-9-carboxylic acid 50 ng/mL).
Results: All subjects tested positive for 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid and Δ9-tetrahydrocannabinol in urine and hair. In sweat samples, Δ9-tetrahydrocannabinol was found in all patches (0.4-2.0 ng/patch); 6 cases were positive for CBN (0.4-0.5 ng/patch) and 3 for CBD (0.4-0.6 ng/patch); 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid was never detected in patches.